Juan E. Rodríguez-Mori

ORCID: 0000-0002-9794-0327
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Public Health and Environmental Issues
  • Renal Transplantation Outcomes and Treatments
  • Dialysis and Renal Disease Management
  • SARS-CoV-2 detection and testing
  • Central Venous Catheters and Hemodialysis
  • Traditional Chinese Medicine Studies
  • Empathy and Medical Education
  • Organ Donation and Transplantation
  • Social Issues and Policies in Latin America
  • Muscle and Compartmental Disorders
  • Transplantation: Methods and Outcomes
  • Complement system in diseases
  • Computational Drug Discovery Methods
  • Renal and Vascular Pathologies
  • Optimism, Hope, and Well-being

Instituto Nacional de Salud del Niño
2018-2022

Revista Conamed
2021

Medico
2021

10.1038/s42255-022-00698-3 article EN Nature Metabolism 2022-11-07

Advances in life expectancy have led to an increase the number of elderly people with end-stage renal disease (ESRD). Scarce information is available on outcomes kidney transplantation (KT) extremely patients based allocation policy prioritizing donor-recipient age matching.We included recipients ≥75 years that underwent KT from similarly aged deceased donors at our institution between 2002 and 2015. Determinants death-censored graft patient survival were assessed by Cox regression.We 138 a...

10.1093/ndt/gfz293 article EN Nephrology Dialysis Transplantation 2019-12-13

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the virus responsible for disease 2019 (COVID‐19), is associated with high incidence of multiorgan dysfunction and death. Angiotensin‐converting enzyme (ACE2), which facilitates SARS‐CoV‐2 host cell entry, may be impacted by angiotensin‐converting inhibitors (ACEIs) angiotensin receptor blockers (ARBs), two commonly used antihypertensive classes. In a multicenter, international randomized controlled trial that began...

10.1111/jch.14011 article EN Journal of Clinical Hypertension 2020-09-16

La microangiopatía trombótica (MAT) es una complicación poco frecuente asociada al uso de tacrolimus en el trasplante renal. Puede estar relacionado a infecciones, rechazo mediado por anticuerpos (RMA), recurrencia enfermedad o MAT novo y toxicidad inhibidores la calcineurina. Por lo general, se presenta como formas incompletas, que hace difícil su diagnóstico, puede provocar lesiones irreversibles. El caso presentado comparte presencia infección viral, datos sugerentes concomitantemente con...

10.35663/amp.2020.374.1056 article ES cc-by ACTA MEDICA PERUANA 2020-12-27

Introducción: El presente artículo resume la guía de práctica clínica (GPC) para el tratamiento farmacológico inicial nefritis lúpica en Seguro Social del Perú (EsSalud). Objetivo: Proveer recomendaciones clínicas basadas evidencia adultos con clase I a V no refractarios EsSalud. Material y Métodos: Se conformó un grupo elaborador (GEG) que incluyó médicos especialistas metodólogos, cual formuló preguntas clínicas. realizaron búsquedas sistemáticas revisiones –cuando fue considerado...

10.35434/rcmhnaaa.2021.144.1461 article ES Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo 2021-12-31

Background Abnormal cellular lipid metabolism appears to underlie SARS-CoV-2 cytotoxicity and may involve inhibition of peroxisome proliferator activated receptor alpha (PPARα). Fenofibrate, a PPAR-α activator, modulates metabolism. Fenofibric acid has also been shown affect the dimerization angiotensin-converting enzyme 2, for SARS-CoV-2. Fenofibrate fenofibric have inhibit replication in cell culture systems

10.21203/rs.3.rs-1933913/v1 preprint EN cc-by Research Square (Research Square) 2022-08-10
Coming Soon ...